Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals

PLoS One. 2015 Apr 1;10(4):e0122822. doi: 10.1371/journal.pone.0122822. eCollection 2015.

Abstract

Background: Opioid use is associated with increased incidence of infectious diseases. Although experimental studies have shown that opioids affect various functions of immune cells, only limited data are available from human studies. Drug use is an important risk factor for HIV transmission; however no data are available whether heroin and/or methadone modulate immune response. Therefore, we examined the effect of heroin and methadone use among HIV-infected individuals on the production of cytokines after ex vivo stimulation with various pathogens.

Methods: Treatment naïve HIV-infected individuals from Indonesia were recruited. Several cohorts of individuals were recruited: 1) using heroin 2) receiving methadone opioid substitution 3) using heroin over 1 year ago and 4) controls (never used opioids). Whole blood was stimulated with Mycobacterium tuberculosis, Candida albicans and LPS for 24 to 48 hours. Cytokine production (IL-1 β, IL-6, IL-10, IFN-α, IFN-γ and TNF-α) was determined using multiplex beads assay.

Results: Among 82 individuals, the cytokine levels in unstimulated samples did not differ between groups. Overall, heroin users had significantly lower cytokine response after exposure to LPS (p<0.05). After stimulation with either M. tuberculosis or C. albicans the cytokine production of all groups were comparable.

Conclusion: The cytokine production after exposure to LPS is significantly down-regulated in HIV-infected heroin users. Interesting, methadone use did not suppress cytokine response, which could have implications guidelines of opioid substitution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cytokines / blood*
  • Female
  • HIV Infections / blood
  • HIV Infections / immunology*
  • Heroin Dependence / blood
  • Heroin Dependence / immunology*
  • Humans
  • Lipopolysaccharides / pharmacology
  • Male
  • Young Adult

Substances

  • Cytokines
  • Lipopolysaccharides

Grants and funding

Hinta Meijerink has a fellowship from Radboud University Medical Centre Nijmegen; Rudi Wisaksana has a fellowship from the Radboud University; Reinout van Crevel has a VIDI grant from the Netherlands Foundation of Scientific Research (NWO); Bachti Alisjahbana has a post-doc fellowship from the Royal Dutch Academy of Arts and Sciences (KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.